ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)

Exploration of the association between gonadotropin genes and their receptor gene variants and the development of polycystic ovary syndrome

Ustenko K.A., Derevyanchuk E.G., Aleksandrova A.A.

1) Rostov State Medical University, Ministry of Health of Russia, Rostov-on-Don, Russia; 2) Southern Federal University, Rostov-on-Don, Russia

Objective: To evaluate the association between gonadotropin genes and their receptor gene variants with the development of polycystic ovary syndrome (PCOS).
Materials and methods: The study included 112 women.  The main group comprised 57 women with PCOS, and the control group comprised 55 women. Exploration of gene variants NM_000894.3(LHB): c. 364G>A (p. Gly122Ser), rs5030774; NM_001382289. 1(FSHB):c.236_237del(p.Val79fs), rs5030646 and NC_000011.10:g.30204981G>A, rs11031006; NM_000233.4 (LHCGR):c.537-235G>A, rs4953616; NM_000145. 4(FSHR):c.919G>A(p.Ala307Thr), rs6165 was performed using allele-specific real-time PCR method followed by statistical data processing.
Results: Our study found no association between PCOS and the variant rs5030774 in the LHB gene and the variant rs5030646 in the FSHB gene. Statistically significant differences were found between the groups under study in distribution of alleles and genotypes across the variant rs11031006 in the FSHB gene, rs4953616 in the LHCGR gene, and rs6165 in the FSHR gene. Allele frequencies of the FSHB A rs11031006 and the FSHR T rs6165 were higher in the control group (59/110 (53.6%) at p=0.008 (OR=0.485 95%, CI 0.284–0.829) and 86/110 (78.2%) at p=0.014 (OR=0.478, 95%, CI 0.265–0.864), respectively, while the prevalence of the allele T rs4953616 of the LHCGR gene was higher in the group of patients with PCOS compared with the control group (87/114 (76,3%) at p=0.002 (OR=2.404, 95% CI 1.354–4.267)).
Conclusion: Exploration of polymorphic loci of gonadotropin genes and their receptor gene variants showed statistically significant association between PCOS and rs11031006 in the FSHB gene, rs4953616 in the LHCGR gene, and rs6165 in the FSHR gene.

Authors' contributions: Ustenko K.A. – collection and processing of primary material, genotyping; Derevyanchuk E.G. – analysis of literature data, statistical analysis of the obtained data, manuscript writing; Alexandrova A.A. – development of the concept and design of the study, manuscript editing.
Conflicts of interest: The authors confirm that they have no conflicts of interest to declare.
Funding: The study was supported by the Russian Science Foundation, project No. 23-15-00464. 
Ethical Approval: The study was approved by the Ethics Committee of the Academy of Biology and Biotechnology named after D.I. Ivanovskiy of the Southern Federal University (Protocol No. 12 of December 24, 2019).
Patient Consent for Publication: All patients provided informed consent for the publication of their data (and associated images)
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Ustenko K.A., Derevyanchuk E.G., Aleksandrova A.A. Exploration of the association between 
gonadotropin genes and their receptor gene variants and the development of polycystic ovary syndrome.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (8): 143-149 (in Russian)
https://dx.doi.org/10.18565/aig.2025.123 

Keywords

gonadotropins
gonadotropin receptors
polycystic ovary syndrome
polymorphic loci of genes
LHB
FSHB
LHCGR
FSHR

References

  1. Беглова А.Ю., Елгина С.И., Гордеева Л.А. Полиморфизм генов CYP11A1, CYP17, CYP19 у женщин репродуктивного возраста с синдромом поликистозных яичников. Акушерство и гинекология. 2019; 12: 148-53. [Beglova A.Yu., Elgina S.I., Gordeeva L.A. Polymorphism of the CYP11A1, CYP17A1, and CYP19A1 genes in reproductive-aged women with polycystic ovary syndrome. Obstetrics and Gynecology. 2019; (12): 148-53 (in Russian)]. https://dx.doi.org/10.18565/aig.2019.12.148-153
  2. Найдукова А.А., Каприна Е.К., Донников А.Е., Чернуха Г.Е. Генетические аспекты формирования синдрома поликистозных яичников. Акушерство и гинекология. 2016; 3: 16-22. [Naidukova A.A., Kaprina E.K., Donnikov A.E., Chernukha G.E. Development of polycystic ovary syndrome: Genetic aspects. Obstetrics and Gynecology. 2016; (3): 16-22 (in Russian)]. https://dx.doi.org/10.18565/aig.2016.3.16-22
  3. GWAS Catalog. Trait: polycystic ovary syndrome. Available at: https://www.ebi.ac.uk/gwas/efotraits/EFO_0000660
  4. Koloda Y.A., Denisova Y.V., Podzolkova N.M. Genetic polymorphisms of reproductive hormones and their receptors in assisted reproduction technology for patients with polycystic ovary syndrome. Drug Metab. Pers. Ther. 2021; 37(2): 111-22. https://dx.doi.org/10.1515/dmpt-2021-0123
  5. Bashir K., Anum A., Idrees I., Manzoor H.T. Elucidating the molecular genetics of genes CYP19A1, CYP17, and FSHR variants association in polycystic ovarian syndrome. Rus. J. Genet. 2024; 60(3): 387-97. https://dx.doi.org/10.1134/S1022795424030049
  6. Chen Z.J., Zhao H., He L., Shi Y., Qin Y., Shi Y. et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16. 3, 2p21 and 9q33. 3. Nat. Genet. 2011; 43(1): 55-9. https://dx.doi.org/10.1038/ng.732
  7. Deswal R., Nanda S., Dang A.S. Association of luteinizing hormone and LH receptor gene polymorphism with susceptibility of polycystic ovary syndrome. Syst. Biol. Reprod. Med. 2019; 65(5): 400-8. https://dx.doi.org/10.1080/19396368.2019.1595217
  8. Dou Y., Zhao R., Wu H., Yu Z., Yin C., Yang J. et al. DENND1A desensitizes granulosa cells to FSH by arresting intracellular FSHR transportation. Sci. China Life Sci. 2024; 67(8): 1620-34. http://dx.doi.org/10.1007/s11427-023-2438-4
  9. Shi Y., Zhao H., Shi Y., Cao Y., Yang D., Li Z. et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 2012; 44(9): 1020-5. http://dx.doi.org/10.1038/ng.2384
  10. Smet M.E., McLennan A. Rotterdam criteria, the end. Australas. J. Ultrasound Med. 2018; 21(2): 59-60. https://dx.doi.org/10.1002/ajum.12096
  11. Гарафутдинов Р.Р., Баймиев Ан.Х., Малеев Г.В., Алексеев Я.И., Зубов В.В., Чемерис Д.А., Кирьянова О.Ю., Губайдуллин И.М., Матниязов Р.Т., Сахабутдинова А.Р., Никоноров Ю.М., Кулуев Б.Р., Баймиев Ал.Х., Чемерис А.В. Разнообразие праймеров для ПЦР и принципы их подбора. Биомика. 2019; 11(1): 23-70. [Garafutdinov R.R., Baymiev An.Kh., Maleev G.V., Alexeyev Ya.I., Zubov V.V., Chemeris D.A., Kiryanova J.Yu., Gubaydullin I.M., Matniyazov R.T., Sakhabutdinova A.R., Nikonorov Yu.M., Kuluev B.R., Baymiev Al.Kh., Chemeris A.V. Diversity of PCR primers and principles of their design. Biomics. 2019; 11(1): 23-70 (in Russian)]. https://dx.doi.org/10.31301/2221-6197.bmcs.2019-04
  12. Petrie A., Bulman J.S., Osborn J.F. Further statistics in dentistry. Part 8: Systematic reviews and meta-analyses. Br. Dent. J. 2003; 194(2): 73-8. https://dx.doi.org/10.1038/sj.bdj.4809877
  13. Kim N.K., Lee E.G., Cho M.S., Nam Y.S., Chung H.M., Chung K.W. et al. Analysis of LHbeta exon 3 (Gly102Ser) gene mutation in infertile patients with endometriosis and polycystic ovary syndrome (PCOS). Kor. J. Fertil. Steril. 2001; 3(27): 291-4.
  14. Ensembl genome browser. Available at: https://www.ensembl.org/index.html
  15. Liaqat I., Jahan N., Krikun G., Taylor H.S. Genetic polymorphisms in Pakistani women with polycystic ovary syndrome. Reprod. Sci. 2015; 22(3): 347-57. http://dx.doi.org/10.1177/1933719114542015
  16. Bohaczuk S.C., Thackray V.G., Shen J., Skowronska-Krawczyk D., Mellon P.L. FSHB transcription is regulated by a novel 5′ distal enhancer with a fertility-associated single nucleotide polymorphism. Endocrinology. 2021; 162(1): bqaa181. https://dx.doi.org/10.1210/endocr/bqaa181
  17. Hayes M.G., Urbanek M., Ehrmann D.A., Armstrong L.L., Lee J.Y., Sisk R. et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat. Commun. 2015; 6: 7502. https://dx.doi.org/10.1038/ncomms8502
  18. Singh S., Kaur M., Beri A., Kaur A. Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study. Sci. Rep. 2023; 13(1): 22841. http://dx.doi.org/10.1038/s41598-023-48881-0
  19. Almawi W.Y., Hubail B., Arekat D.Z., Al-Farsi S.M., Al-Kindi S.K., Arekat M.R. et al. Leutinizing hormone / choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome. J. Assist. Reprod. Genet. 2015; 32(4): 607-14. https://dx.doi.org/10.1007/s10815-015-0427-0
  20. Renzi A., Petersen C.G., Vagnini L., Oliveira-Pelegrin G.R., Mauri A.L., Massaro F.C. et al. The fshr gene polymorphism (rs 6165-ala/ala genotype) is associated with the use of higher doses of recombinant FSH during IVF/ICSI treatment. Fertil. Steril. 2014; 102(3): e120-1. https://dx.doi.org/10.1016/j.fertnstert.2014.07.412
  21. Kim J.J., Choi Y.M., Hong M.A., Chae S.J., Hwang K., Yoon S.H. et al. FSH receptor gene p. Thr307Ala and p. Asn680Ser polymorphisms are associated with the risk of polycystic ovary syndrome. J. Assist. Reprod. Genet. 2017; 34(8): 1087-93. https://dx.doi.org/10.1007/s10815-017-0953-z
  22. Du J., Zhang W., Guo L., Zhang Z., Shi H., Wang J. et al. Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome. Mol. Genet. Metab. 2010; 100(3): 292-5. https://dx.doi.org/10.1016/j.ymgme.2010.03.018

Received 10.05.2025

Accepted 30.07.2025

About the Authors

Ksenia A. Ustenko, student, Rostov State Medical University, Ministry of Health of Russia, 344022, Russia, Rostov-on-Don, per. Nakhichevansky, 29, +7(928) 770-33-34, ustenko.ksusha@gmail.com, https://orcid.org/0009-0003-3992-1923
Ekaterina G. Derevyanchuk, PhD, Associate Professor, Southern Federal University, 344090, Russia, Rostov-on-Don, Stachki Ave., 194 build. 1, +7(928)132-29-88, biolab2008@yandex.ru, https://orcid.org/0000-0002-6231-3454
Anzhela A. Aleksandrova, PhD, Associate Professor, Southern Federal University, 344090, Russia, Rostov-on-Don, Stachki Ave., 194 build. 1, +7(928)190-58-30, aalexsandrova@mail.ru, https://orcid.org/0000-0002-1948-4995
Corresponding author: Ekaterina G. Derevyanchuk, biolab2008@yandex.ru

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.